Katherine Tarlock

Seattle Children's Hospital

Also affiliated with Center for Cancer and Blood Disorders

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group”.

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Blood(2021)10.1182/blood.2020009652

N/A

0DataRank · unranked

122 citations

Adam J. Lamble, Yi‐Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Michael R. Loken +13 more

Mesothelin is a novel cell surface disease marker and potential therapeutic target in acute myeloid leukemia

Blood Advances(2021)10.1182/bloodadvances.2021004424

N/A

0DataRank · unranked

41 citations

Sonali P. Barwe, Anilkumar Gopalakrishnapillai, Rhonda E. Ries, Todd A. Alonzo, Robert B. Gerbing +16 more

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes

Blood Advances(2021)10.1182/bloodadvances.2021004965

N/A

0DataRank · unranked

11 citations

Jenny L. Smith, Yi‐Cheng Wang, Kassra Taghizadeh, Amanda R. Leonti, Rhonda E. Ries +19 more

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10018

N/A

0DataRank · unranked

0 citations

Xiaowei Liu, Charles G. Minard, Sarah Menig, Joel M. Reid, Emasenyie Isikwei +6 more

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia

Nature Communications(2022)10.1038/s41467-022-33244-6

N/A

0DataRank · unranked

49 citations

Jenny L. Smith, Jason E. Farrar, Yi‐Cheng Wang, Masayuki Umeda, Rhonda E. Ries +21 more

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia

Haematologica(2023)10.3324/haematol.2022.281653

N/A

0DataRank · unranked

76 citations

Jenny L. Smith, Lauren Harmon, Rhonda E. Ries, Yi-Cheng J. Wang, Todd A. Alonzo +32 more

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712

Pediatric Blood & Cancer(2023)10.1002/pbc.30672

N/A

0DataRank · unranked

3 citations

Xiaowei Liu, Charles G. Minard, Emasenyie Isikwei, Joel M. Reid, Terzah M. Horton +4 more

CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children’s Oncology Group

Haematologica(2024)10.3324/haematol.2023.283757

N/A

0DataRank · unranked

10 citations

Chad A. Hudson, Todd A. Alonzo, Robert B. Gerbing, Laura Pardo, Amanda R. Leonti +18 more

Multi-omics analysis reveals CLEC2A is a leukemia-restricted CART target in KMT2A-rearranged Acute Myeloid Leukemia

Research Square(2025)10.21203/rs.3.rs-7768680/v1

N/A

0DataRank · unranked

0 citations

Derek H. Janssens, Margaret G. Hines, Seungmin Shin, Grace Hawkins, Melia Blankenfeld +26 more

Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.12.003

N/A

0DataRank · unranked

0 citations

Ted Gooley, Monica S. Thakar, Scott N. Furlan, Corinne Summers, Danielle Kirkey +11 more